Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » Lucence Obtains CLIA Certification for Palo Alto Lab

Lucence Obtains CLIA Certification for Palo Alto Lab

Dec 10, 2020
|
staff reporter

NEW YORK – Lucence said on Thursday that its laboratory in Palo Alto, California has received CLIA certification from the Centers for Medicaid & Medicare Services.

Known as Lucence Health in the US, the Singapore-based firm plans to quickly scale US-based testing capacity for its LiquidHallmark liquid biopsy assay.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Breathe It Out

Researchers are developing a breath test to determine how severe patients' methylmalonic acidemia disease is, FierceBiotech reports.

The Next Batch

NPR reports that vaccine developers are working on SARS-CoV-2 vaccines that are easier to store or administer than the current crop.

Switch for the Second

Reuters reports that France is to recommend that people under 55 who received one dose of AstraZeneca's SARS-CoV-2 vaccine receive a different vaccine for their second dose.

Science Reviews How Non-Genetic DNA Features Expand Utility of Liquid Biopsies, Presents Study of Enzymes in DNA Methylation

In Science this week: review discusses advances in liquid biopsies, and more.

What's Popular?

In Liquid Biopsy

  1. Armed With $55M in New Funding, Nucleix to Further Invest in Early-Stage Lung Cancer Dx

    Premium

  2. Nucleix Raises $55M in Financing Round

  3. Scottish Liquid Biopsy Startup BioCaptiva Raises £1M in Seed Funding

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.